Category: Premalignant cell line
Cancer Type: Oral Leukoplakia
MSK-Leuk 1 is a human oral leukoplakia cancer cell line.
This cell line was established from a female with oral leukoplakia.
- Peter G. Sacks, MD, former Associate Attending, Surgery, Memorial Hospital, Memorial Sloan Kettering Cancer Center
PubMed=8842478; DOI=10.1007/BF00049486 Sacks P.G. Cell, tissue and organ culture as in vitro models to study the biology of squamous cell carcinomas of the head and neck.Cancer Metastasis Rev. 15:27-51(1996)
This cell line may be licensed nonexclusively for research or commercial purposes.
- Express License: For internal research purposes by a for-profit entity: Fill out MSK’s Core Express License; see here for links to the online fillable Core Express License, as well as a PDF version. For detailed guidance on how to fill out this webform, see here. Please note: In order to streamline and expedite the licensing of select MSK cell lines, the terms of this non-exclusive license are non-negotiable. This license is only available for select cell lines, including this one. Once this license has been executed by MSK, you will receive a signed copy and payment instructions; all payments up to $10,000 must be made by credit card.
- Commercial License: Contact MSK’s Tangible Research Materials team at [email protected].
- For non-licensing requests from academic-research institutions: Contact MSK’s Antibody & Bioresource Core Facility at [email protected].